A carregar...
Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs Hospital
PURPOSE: As a result of a cost savings initiative, the Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, selected liraglutide as its preferred glucagon-like peptide 1 receptor agonist for the treatment of patients with type 2 diabetes mellitus with a preferred maximum daily dose...
Na minha lista:
| Publicado no: | Fed Pract |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontline Medical Communications Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7592900/ https://ncbi.nlm.nih.gov/pubmed/33132682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12788/fp.0057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|